Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Suzuki

Showing results (41-50 of 563) with videos related to

Pageof 57
Sort By:
Biotechnology Progress|May 1, 1990
Enhanced antibody production at slowed growth rates: experimental demonstration and a simple structured modelE Suzuki, D F Ollis
Biotechnology and Bioengineering|December 20, 1989
Cell cycle model for antibody production kineticsE Suzuki, D F Ollis
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 26, 1998
[The measurement of the peripheral vascular flow by imaging techniques]E Suzuki, H Yasuda, R Kikkawa
Gan|October 1, 1981
Metabolic fate of n-methyl-N-dodecylnitrosamine in the rat, in relation to its carcinogenicity to the urinary bladderE Suzuki, M Mochizuki, M Okada
Chemical & Pharmaceutical Bulletin|December 1, 1978
Syntheses of N-alkyl-N-(hydroxy- or oxo-alkyl) nitrosamines related to N-butyl-N-(4-hydroxybutyl) nitroamine, a potent bladder carcinogenM Okada, E Suzuki, M Iiyoshi
Shika Zairyo, Kikai = Journal of the Japanese Society for Dental Materials and Devices|September 1, 1984
[Properties of dental zinc phosphate cements after mechanical mixing (2). Viscosity changes in the early setting process]K Kuga, E Suzuki, T Miyaji
Arerugi = [Allergy]|October 22, 1998
[Cough-variant asthma successfully treated with suplatast tosilate]K Fujimori, E Suzuki, M Arakawa
Gan|December 1, 1976
Carcinogenicity of N-nitrosamines related to N-butyl-N-(4-hydroxybutyl)nitrosamine and N,N,-dibutylnitrosamine in ACI/N ratsM Okada, E Suzuki, Y Hashimoto
Journal of Nutritional Science and Vitaminology|October 1, 1991
Comparison of absorption of erythorbic acid and ascorbic acid in guinea pig small intestineE Suzuki, T Kurata, N Arakawa
Oncogene|June 28, 2016
Rituximab inhibits the constitutively activated PI3K-Akt pathway in B-NHL cell lines: involvement in chemosensitization to drug-induced apoptosisE Suzuki, K Umezawa, B Bonavida
Pageof 57

Showing results (41-50 of 563) with videos related to

Sort By:
Pageof 57
Biotechnology Progress|May 1, 1990
Enhanced antibody production at slowed growth rates: experimental demonstration and a simple structured modelE Suzuki, D F Ollis
Biotechnology and Bioengineering|December 20, 1989
Cell cycle model for antibody production kineticsE Suzuki, D F Ollis
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 26, 1998
[The measurement of the peripheral vascular flow by imaging techniques]E Suzuki, H Yasuda, R Kikkawa
Gan|October 1, 1981
Metabolic fate of n-methyl-N-dodecylnitrosamine in the rat, in relation to its carcinogenicity to the urinary bladderE Suzuki, M Mochizuki, M Okada
Chemical & Pharmaceutical Bulletin|December 1, 1978
Syntheses of N-alkyl-N-(hydroxy- or oxo-alkyl) nitrosamines related to N-butyl-N-(4-hydroxybutyl) nitroamine, a potent bladder carcinogenM Okada, E Suzuki, M Iiyoshi
Shika Zairyo, Kikai = Journal of the Japanese Society for Dental Materials and Devices|September 1, 1984
[Properties of dental zinc phosphate cements after mechanical mixing (2). Viscosity changes in the early setting process]K Kuga, E Suzuki, T Miyaji
Arerugi = [Allergy]|October 22, 1998
[Cough-variant asthma successfully treated with suplatast tosilate]K Fujimori, E Suzuki, M Arakawa
Gan|December 1, 1976
Carcinogenicity of N-nitrosamines related to N-butyl-N-(4-hydroxybutyl)nitrosamine and N,N,-dibutylnitrosamine in ACI/N ratsM Okada, E Suzuki, Y Hashimoto
Journal of Nutritional Science and Vitaminology|October 1, 1991
Comparison of absorption of erythorbic acid and ascorbic acid in guinea pig small intestineE Suzuki, T Kurata, N Arakawa
Oncogene|June 28, 2016
Rituximab inhibits the constitutively activated PI3K-Akt pathway in B-NHL cell lines: involvement in chemosensitization to drug-induced apoptosisE Suzuki, K Umezawa, B Bonavida
Pageof 57